Navigation Links
Reportlinker Adds Therapeutic Proteins to 2014
Date:2/1/2011

NEW YORK, Feb. 1, 2011 /PRNewswire/ -- Reportlinker.com announces that a new market research report is available in its catalogue:

Therapeutic Proteins to 2014

http://www.reportlinker.com/p0369399/Therapeutic-Proteins-to-2014.html

In recent years, the number of protein-based pharmaceuticals reaching the marketplace has increased exponentially. The clinical application of these drugs is limited by a lack of desirable attributes for adequate absorption or distribution. It therefore becomes critical to formulate these drugs into safe, stable and efficacious delivery systems. Because these drugs face formidable enzymatic and penetration barriers when administered orally, peptide and protein drugs continue to be developed almost exclusively for parenteral administration. These combination drug-device products, where the drug and device are clinically tested and approved as a single product entity, are becoming one of the fastest new drug categories. On a unit basis, in spite of their higher cost protein drugs are growing in excess of fifteen percent annually. The growth of protein drug products is having a significant effect on the way drugs and devices are developed. Cooperation between device designers and drug developers is occurring much earlier in the drug development cycle, allowing device designs in many cases to be tailored to the bioavailability targets and pharmacokinetic profiles of specific drug therapies.

To order this report:: Therapeutic Proteins to 2014

More  Market Rese
'/>"/>

SOURCE Reportlinker
Copyright©2010 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2

Related biology technology :

1. Reportlinker Adds Biochips - Products, Applications, Technologies and End-Use Markets Growth Analysis, 2009-2015
2. Reportlinker Adds Cell Therapy - Technologies, Markets and Companies
3. Reportlinker Adds The 2011 Molecular Diagnostics Market: DNA Probes and Biochips -- New Product Development Opportunities and Business Expansion Strategies for Instrument and Reagent Suppliers
4. Reportlinker Adds The 2011 Immunoprotein Diagnostics Market: US, Europe, Japan Test Volume and Sales Forecasts by Country and Market Segment
5. Reportlinker Adds The 2011 Clinical Chemistry and Immunodiagnostics Markets: US, Europe, Japan Product Development Opportunities and Business Expansion Strategies for Instrumentand Reagent Suppliers
6. Reportlinker Adds Biologic Therapeutic Drugs: Technologies and Global Markets
7. Reportlinker Adds The Future of In Vitro and In Vivo Diagnostic Integration
8. Reportlinker Adds Vaccine Technologies and Global Markets
9. Reportlinker Adds Future US In Vitro Diagnostics Market: Strategic Implications of Emerging Reimbursement, Technological and Market Trends Through 2018
10. Reportlinker Adds Hospital General Radiology Census
11. Reportlinker Adds Hospital Computer Tomography (CT) Census
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/17/2013)... ALTO, Calif. , May 17, 2013 /PRNewswire/ ... it has achieved 50% enrollment of the total ... to evaluate the safety and preliminary efficacy of ... Cells) therapy for Knee Osteoarthritis (KOA). To date ... (SAE) reported. The Phase I open ...
(Date:5/17/2013)... , May 17, 2013 /PRNewswire-iReach/ -- Aridis ... been reached with Switzerland -based ... anti-infective human monoclonal antibody (mAb) products, and technologies. ... mAb products for treatment of infections by common ... Staphylococcus aureus , Pseudomonas aeruginosa , ...
(Date:5/17/2013)... May 17, 2013 Men’s skin is biologically ... La-roche Posay ) and has been known to react more ... men may be far from puberty, other acne causing factors ... causing breakouts, and threatening skin with unsightly acne scars. Adult ... Men’s Health on how to reduce and prevent ...
(Date:5/17/2013)... RURO Inc. is pleased to ... versatile refinement to the smart management solution. , ... advanced methodical management for transgenic animal colonies, genotyping ... network-based platform provides user access with a plethora ... to emphasize streamlined tasks, such as animal relocation ...
Breaking Biology Technology:Cellular Biomedicine Group Achieves 50% Enrollment Milestone in Phase I Clinical Trial for Knee Osteoarthritis 2Aridis Pharmaceuticals Announces Acquisition of Monoclonal Antibody Products and Technologies From Kenta Biotech 2Aridis Pharmaceuticals Announces Acquisition of Monoclonal Antibody Products and Technologies From Kenta Biotech 3Adult Acne Treatment, Probiotic Action Shares New Insight on Why Men’s Skin Scars from Acne and How to Prevent It 2RURO Introduces ezColony 4.1 – The Versatile Transgenic Animal Colony Management Software 2
... VIENNA, Va., March 10 CEL-SCI Corporation (NYSE Alternext ... to launch a new manufacturing process that could allow ... to maintain their potency and thereby potentially also their ... developed by CEL-SCI may also significantly accelerate the time ...
... Take Market Share Away from Lucentis from 2012 ... Decision ResourcesWALTHAM, Mass., March 10 Decision Resources, ... firms for pharmaceutical and healthcare issues, finds that ... macular degeneration (AMD) market through 2012 will be ...
... Tolerx, Inc., today announced that DEFEND ( D urable ... arly or N ew Onset Type 1 D ... targeted immunotherapeutic, has begun enrollment of new onset autoimmune type ... cell function subsequent to the administration of otelixizumab is the ...
Cached Biology Technology:CEL-SCI Corporation to Launch Aseptic Filling for Stem Cell Produced Therapies and Other Biological Products 2CEL-SCI Corporation to Launch Aseptic Filling for Stem Cell Produced Therapies and Other Biological Products 3CEL-SCI Corporation to Launch Aseptic Filling for Stem Cell Produced Therapies and Other Biological Products 4Robust Annual Growth Through 2012 in the Age-Related Macular Degeneration Market Will Be Driven by Expanding Use of Lucentis in Europe 2Robust Annual Growth Through 2012 in the Age-Related Macular Degeneration Market Will Be Driven by Expanding Use of Lucentis in Europe 3Tolerx Expands Phase 3 'DEFEND' Trial of Otelixizumab in Europe 2Tolerx Expands Phase 3 'DEFEND' Trial of Otelixizumab in Europe 3Tolerx Expands Phase 3 'DEFEND' Trial of Otelixizumab in Europe 4
(Date:5/16/2013)... predict the stability of today,s largest ice sheets in Greenland ... years ago, for example when Earth was going through ... a high sea level due to ice sheet collapse at ... that if the world,s largest ice sheets collapsed in the ... modern, progressively warming world. , However, a new groundbreaking ...
(Date:5/16/2013)... layer lining the body,s blood vessels, is extremely ... thickness, this super-tenuous structure routinely withstands blood flow, ... a unique and highly dynamic barrier that maintains ... body,s circulatory system. , It,s also extremely adaptable. ... breached to enable immune cells to reach ...
(Date:5/16/2013)... , May 16, 2013 Integrated ... combination with a custom thin film transistor camera ... forensic quality roll image in the smallest and ... Sherlock, an Appendix F Mobile ID FAP 45, ... 95% reduction in size and weight when compared ...
Breaking Biology News(10 mins):World's biggest ice sheets likely more stable than previously believed 2Endothelium, heal thyself 2Endothelium, heal thyself 3Endothelium, heal thyself 4
... the first time, scientists have described not only the identities ... in this case, a mouse macrophage or white blood ... and change over time to a bacterial stimulus triggering the ... of the Journal of Biological Chemistry , lead author ...
... of time, the colonial hydrology of the northeastern U.S. has ... social scientists. The results, which extend as far back ... the journal Environmental Science & Technology (ES&T). ... of the past, and will lead to a better understanding ...
... / ST. PAUL (December 1, 2010) University of ... is among an international group of researchers that has ... of sexual maturation in women. Many of these genes ... energy metabolism. Prior to the multi-institutional study, only four ...
Cached Biology News:Researchers describe first functioning 'lipidome' of mouse macrophage 2Researchers describe first functioning 'lipidome' of mouse macrophage 3America's colonial hydrologic history recreated 2U of M researcher helps unlock 30 new genes responsible for early onset puberty 2
quantitation of phosphatase activity, evaluation of hits and leads from HTS...
... ISO 9001:2000 Certified USDA Research Registered ... SOP's Training AALAS Certified Technicians ... Procedures GLP Documentation Upon Request Focus ... point for all your custom immunology service ...
Request Info...
Request Info...
Biology Products: